Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults
Conditions
Interventions
Dapivirine gel (0.05%)
Universal HEC placebo gel
Locations
1
United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Start Date
September 29, 2015
Primary Completion Date
September 1, 2017
Completion Date
November 1, 2017
Last Updated
February 8, 2017
Lead Sponsor
International Partnership for Microbicides, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions